Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus

BACKGROUND: A novel urine lipoarabinomannan assay (FujiLAM) has higher sensitivity and higher cost than the first-generation AlereLAM assay. We evaluated the cost-effectiveness of FujiLAM for tuberculosis testing among hospitalized people with human immunodeficiency virus (HIV), irrespective of symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Krishna P, Denkinger, Claudia M, Broger, Tobias, McCann, Nicole C, Gupta-Wright, Ankur, Kerkhoff, Andrew D, Pei, Pamela P, Shebl, Fatma M, Fielding, Katherine L, Nicol, Mark P, Horsburgh, C Robert, Meintjes, Graeme, Freedberg, Kenneth A, Wood, Robin, Walensky, Rochelle P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492225/
https://www.ncbi.nlm.nih.gov/pubmed/33200169
http://dx.doi.org/10.1093/cid/ciaa1698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492225/
https://www.ncbi.nlm.nih.gov/pubmed/33200169
http://dx.doi.org/10.1093/cid/ciaa1698

Ejemplares similares